Absci (ABSI) Net Margin (2020 - 2026)
Absci (ABSI) posted Net Margin of 13766.98% for Q1 2026, down 202.7% sequentially from 4548.0% in Q4 2025, and down 1153237.0% YoY from N/an in Q1 2025.
Absci (ABSI) Net Margin (2020 - 2026) Analysis & Trends
Absci has reported Net Margin for 7 years, with the latest figure at 13766.98% in Q1 2026.
- Quarterly Net Margin fell 1153237.0% year-over-year to 13766.98% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 6450.76% (down 421863.0% YoY) and the FY2025 annual result came in at 4113.68%, down 183962.0% from the prior year.
- Net Margin fell to 13766.98% in Q1 2026 per ABSI's latest filing, from 4548.0% in the prior quarter.
- Over five years, Net Margin peaked at 1237.66% in Q2 2023 and troughed at 13766.98% in Q1 2026.
- A 5-year average of 4754.04% and a median of 4358.35% in 2024 frame the typical range for Net Margin.
- The sharpest annual moves came in 2022 and 2026: Net Margin surged 855594 bps in 2022, then plunged 1153237 bps in 2026.
- Over 5 years, Net Margin stood at 5743.66% in 2022, then decreased by 21 bps to 6965.98% in 2023, then jumped by 37 bps to 4358.35% in 2024, then declined by 4 bps to 4548.0% in 2025, then plunged by 203 bps to 13766.98% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 13766.98%, 4548.0%, and 7594.18% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 30.33% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.90% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 30.98% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 12.09% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 12.74% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -3.12% |
| 10 | Absci | 1.58 Bn | 1.37 Bn | - | -10,443.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -10,443.40% |
| Mar 31, 2026 | -13,766.98% |
| Dec 31, 2025 | -4,548.00% |
| Sep 30, 2025 | -7,594.18% |
| Jun 30, 2025 | -5,154.97% |
| Mar 31, 2025 | -2,234.61% |
| Dec 31, 2024 | -4,358.35% |
| Sep 30, 2024 | -1,610.70% |
| Jun 30, 2024 | -1,948.82% |
| Mar 31, 2024 | -2,447.10% |
| Dec 31, 2023 | -6,965.98% |
| Sep 30, 2023 | -2,956.18% |
| Jun 30, 2023 | -1,237.66% |
| Mar 31, 2023 | -1,840.43% |
| Dec 31, 2022 | -5,743.66% |
| Sep 30, 2022 | -7,468.22% |
| Jun 30, 2022 | -2,862.28% |
| Mar 31, 2022 | -8,080.55% |
| Dec 31, 2021 | 1,171.06% |
| Sep 30, 2021 | -16,024.16% |